Hotel Advertising Transparency Act of 2022

H.R. 133: MERIT Act H.R. 2666: Medicaid VBPs for Patients Act or MVP Act H.R. 8261: Preserving Telehealth, Hospital, and Ambulance Access Act S. 1450: Cutting Medicare Prescription Drug Prices in Half Act Inflation Reduction Act of 2022 (P.L. 117-169) Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Rebate policy issues Insulin policy issues Value-based purchasing arrangements policy issues Anti-Kickback Statute policy issues Center for Medicare and Medicaid Innovation (CMMI) and model policy issues CMMI Cell and Gene Therapy Access Model Medicaid rebates and waiver policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues CMS Guidance on Medicare Part B and D Inflation Rebates Medicaid Drug Rebate Program Final rule (CMS-2434-F)

Client expense: $7,560,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.3430: Better Mental Healthcare, Lower Cost Drugs & Extenders Act-provisions related to PBMs and pharmacy contracting. S.2973: Modernizing and Ensuring PBM Accountability Act - provisions related to PBM contracting, audits and disclosures. H.R.5526: Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception. Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration. Implementation of H.R. 5376 (117th Congress)/P.L. 117-169 The Inflation Reduction Act-provisions related to changes in Medicare Part D and government negotiation of drug prices. Sec.302: Arrangements with Pharmacy Benefit Managers with Respect to Prescription Drug Plans and MA-PD Plans, of H.R. 8261, Preserving Telehealth, Hospital, and Ambulance Access Act. H.R.7623: Telehealth Modernization Act of 2024, Section on Arrangements with Pharmacy Benefit Managers with Respect to Prescription 23 Drug Plans and MA-PD Plans.

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.3430: "Better Mental Healthcare, Lower Cost Drugs & Extenders Act," provisions related to PBMs and pharmacy contracting. S.2973: "Modernizing and Ensuring PBM Accountability Act," provisions related to PBM contracting, audits and disclosures. H.R.5526: "Seniors Access to Critical Medications Act of 2023," provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception. Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration. Implementation of H.R. 5376 (117th Congress)/P.L. 117-169: The Inflation Reduction Act-provisions related to changes in Medicare Part D and government negotiation of drug prices. Sec. 302, Arrangements with Pharmacy Benefit Managers with Respect to Prescription Drug Plans and MA-PD Plans, of H.R. 8261, Preserving Telehealth, Hospital, and Ambulance Access Act. H.R.7623: "Telehealth Modernization Act of 2024", Sec. 202, Arrangements with Pharmacy Benefit Managers with Respect to Prescription Drug Plans and MA-PD Plans.

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE